223 related articles for article (PubMed ID: 25158772)
21. Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study.
Palacio S; McClure LA; Benavente OR; Bazan C; Pergola P; Hart RG
Stroke; 2014 Sep; 45(9):2689-94. PubMed ID: 25034716
[TBL] [Abstract][Full Text] [Related]
22. Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy.
Jones DW; Goodney PP; Conrad MF; Nolan BW; Rzucidlo EM; Powell RJ; Cronenwett JL; Stone DH
J Vasc Surg; 2016 May; 63(5):1262-1270.e3. PubMed ID: 26947237
[TBL] [Abstract][Full Text] [Related]
23. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].
Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332
[No Abstract] [Full Text] [Related]
24. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
Roe MT; Goodman SG; Ohman EM; Stevens SR; Hochman JS; Gottlieb S; Martinez F; Dalby AJ; Boden WE; White HD; Prabhakaran D; Winters KJ; Aylward PE; Bassand JP; McGuire DK; Ardissino D; Fox KA; Armstrong PW
Circulation; 2013 Aug; 128(8):823-33. PubMed ID: 23852610
[TBL] [Abstract][Full Text] [Related]
25. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.
Hart RG; Pearce LA; Bakheet MF; Benavente OR; Conwit RA; McClure LA; Talbert RL; Anderson DC
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):618-24. PubMed ID: 23800503
[TBL] [Abstract][Full Text] [Related]
26. The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
Benavente OR; White CL; Pearce L; Pergola P; Roldan A; Benavente MF; Coffey C; McClure LA; Szychowski JM; Conwit R; Heberling PA; Howard G; Bazan C; Vidal-Pergola G; Talbert R; Hart RG;
Int J Stroke; 2011 Apr; 6(2):164-75. PubMed ID: 21371282
[TBL] [Abstract][Full Text] [Related]
27. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
28. Clopidogrel added to aspirin adds no benefit but bleeding risk in patients with recent lacunar stroke.
Diener HC; Weber R
Stroke; 2013 Mar; 44(3):861-3. PubMed ID: 23339960
[No Abstract] [Full Text] [Related]
29. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study.
Boehme AK; McClure LA; Zhang Y; Luna JM; Del Brutto OH; Benavente OR; Elkind MS
Stroke; 2016 Mar; 47(3):659-67. PubMed ID: 26888535
[TBL] [Abstract][Full Text] [Related]
32. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
[TBL] [Abstract][Full Text] [Related]
33. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Han S; Lee SG; Seong IW; Rha SW; Jeong MH; Lim DS; Yoon JH; Hur SH; Choi YS; Yang JY; Lee NH; Kim HS; Lee BK; Kim KS; Lee SU; Chae JK; Cheong SS; Suh IW; Park HS; Nah DY; Jeon DS; Seung KB; Lee K; Jang JS; Park SJ
Circulation; 2014 Jan; 129(3):304-12. PubMed ID: 24097439
[TBL] [Abstract][Full Text] [Related]
34. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.
Wang Y; Wang Y; Zhao X; Liu L; Wang D; Wang C; Wang C; Li H; Meng X; Cui L; Jia J; Dong Q; Xu A; Zeng J; Li Y; Wang Z; Xia H; Johnston SC;
N Engl J Med; 2013 Jul; 369(1):11-9. PubMed ID: 23803136
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet Therapy After Noncardioembolic Stroke.
Greving JP; Diener HC; Reitsma JB; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Algra A
Stroke; 2019 Jul; 50(7):1812-1818. PubMed ID: 31177983
[TBL] [Abstract][Full Text] [Related]
36. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
[TBL] [Abstract][Full Text] [Related]
37. Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial.
Nakajima M; Pearce LA; Ohara N; Field TS; Bazan C; Anderson DC; Hart RG; Benavente OR;
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1052-8. PubMed ID: 25817614
[TBL] [Abstract][Full Text] [Related]
38. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW;
N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
[TBL] [Abstract][Full Text] [Related]
40. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
Alcocer F; Novak Z; Combs BR; Lowman B; Passman MA; Mujib M; Jordan WD
J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
